Characterization of Biotechnology Pharmaceutical Products: Symposium, Washington, D. C., December, 1995 (Developments in Biological Standardizati Series, 96)

This selection of papers from a conference on "Characterization of Biotechnology Pharmaceutical Products", addresses such matters as the biological importance and evaluation of glycosylation; the evaluation and concerns for antigenic potential in respect of potency, impurities and DNA and plasmid products. Other topics discussed include the examination of case studies of protein-based pharmaceuticals, and evaluation of relevant peptides, polysaccharides and antibodies.